Circulating sclerostin levels and markers of bone turnover in chinese-american and white women

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4736-4743

  Costa, Aline G ^a,b   Walker, Marcella D ^a   Zhang, Chiyuan A ^a   Cremers, Serge ^a   Dworakowski, Elzbieta ^a   McMahon, Donald J ^a   Liu, George ^c   Bilezikian, John P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c NEW YORK DOWNTOWN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5B; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PROCOLLAGEN; SCLEROSTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN AMERICAN; BONE DENSITY; BONE STRUCTURE; BONE TURNOVER; CARBOXY TERMINAL TELOPEPTIDE BLOOD LEVEL; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME SPECIFICITY; FEMALE; HUMAN; OSTEOCALCIN BLOOD LEVEL; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RACE DIFFERENCE; SCLEROSTIN BLOOD LEVEL; UNIVERSITY HOSPITAL;

ACID PHOSPHATASE; ADULT; AGED; ALKALINE PHOSPHATASE; ASIAN AMERICANS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; CHINA; COHORT STUDIES; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRACTURES, BONE; GENETIC MARKERS; HOSPITALS, UNIVERSITY; HUMANS; ISOENZYMES; MENOPAUSE; MIDDLE AGED; NEW YORK CITY; PEPTIDES; RISK FACTORS;

EID: 84889776955     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2106     Document Type: Article

References (40)

1. Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20:185-194.
2. Walker MD, Babbar R, Opotowsky AR, et al. A referent bone mineral density database for Chinese American women. Osteoporos Int. 2006;17:878-887.
3. Russell-Aulet M, Wang J, Thornton JC, Colt EW, Pierson RN Jr. 1993 Bone mineral density and mass in a cross-sectional study of white and Asian women. J Bone Miner Res. 8:575-582.
4. Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Gold-berg J. Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1997;146:502-509.
5. Finkelstein JS, Lee ML, Sowers M, et al. Ethnic variation in bone density in premenopausal and early perimenopausal women: Effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002;87:3057-3067.
6. Wang XF, Wang Q, Ghasem-Zadeh A, et al. Differences in macroand microarchitecture of the appendicular skeleton in young Chinese and white women. J Bone Miner Res. 2009;24:1946-1952.
7. Walker MD, Liu XS, Stein E, et al. Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res. 2011;26:1392-1398.
8. Walker MD, McMahon DJ, Udesky J, Liu G, Bilezikian JP. Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: Explanation of a paradox. J Bone Miner Res. 2009;24:1953-1959.
9. Liu XS, Walker MD, McMahon DJ, et al. Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women. J Bone Miner Res. 2011;26:1783-1792.
10. Walker MD, Liu XS, Zhou B, et al. Premenopausal and postmenopausal differences in bone microstructure and mechanical competence in Chinese-American and white women. J Bone Miner Res. 2013;28:1308-1318.
11. Brixen K, Eriksen EF. Validation of biochemical markers of bone turnover. In: Seibel MJ, Robins SP, Bilezikian JP, eds. Dynamics of Bone and Cartilage Metabolism. 2nd ed. San Diego, CA: Academic Press; 2006:583-594.
12. Poole KE, van Bezooijen RL, Loveridge N, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005;19:1842-1844.
13. van Bezooijen RL, ten Dijke P, Papapoulos SE, Löwik CW. SOST/ sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev. 2005;16:319-327.
14. Balemans W, Ebeling M, Patel N, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001;10:537-543.
15. Balemans W, Patel N, Ebeling M, et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet. 2002;39:91-97.
16. Li X, Ominsky MS, Niu QT, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23:860-869.
17. Li X, Warmington KS, Niu QT, et al. Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats. J Bone Miner Res. 2010;25:2647-2656.
18. Padhi D, Jang G, Stouch B, Fang L, Posvar E. Single-dose, placebocontrolled, randomized study ofAMG785, a sclerostin monoclonal antibody. J Bone Miner Res. 2011;26:19-26.
19. OminskyMS,Li C, Li X, et al. Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res. 2011;26:1012-1021.
20. Mirza FS, Padhi ID, Raisz LG, Lorenzo JA. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab. 2010;95:1991-1997.
21. Mödder UI, Hoey KA, Amin S, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res. 2011;26:373-379.
22. van Lierop AH, Witteveen JE, Hamdy NA, Papapoulos SE. Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls. Eur J Endocrinol. 2010;163: 833-837.
23. Gaudio A, Pennisi P, Bratengeier C, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010;95:2248-2253.
24. Costa AG, Cremers S, Rubin MR, et al. Circulating sclerostin in disorders of parathyroid gland function. J Clin Endocrinol Metab. 2011;96:3804-3810.
25. Amrein K, Amrein S, Drexler C, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab. 2012; 97:148-154.
26. Armamento-Villareal R, Sadler C, Napoli N, et al. Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res. 2012;27:1215-1221.
27. Mödder UI, Clowes JA, Hoey K, et al. Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res. 2011;26:27-34.
28. Arasu A, Cawthon PM, Lui LY, et al; Study of Osteoporotic Fractures Research G. Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab. 2012;97:2027-2032
29. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936-942.
30. Bonnick SL, Johnston CC Jr, Kleerekoper M, et al. Importance of precision in bone density measurements. J Clin Densitom. 2001;4: 105-110.
31. Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005;90:6508-6515.
32. Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas PD. Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res. 2008;23:392-399.
33. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: The OFELY study. J Bone Miner Res. 2007;22: 425-433.
34. Finkelstein JS, Sowers M, Greendale GA, et al. Ethnic variation n in bone turnover in pre- and early perimenopausal women: Effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002;87:3051-3056.
35. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res. 1996;11:1531-1538.
36. Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: The OFELY study. J Bone Miner Res. 2005;20:1813-1819.
37. Johnell O, Kanis JA, Black DM, et al. Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. J Bone Miner Res. 2004;19: 764-772.
38. Sheng Z, Tong D,Ou Y, et al. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clin Endocrinol (Oxf). 2012;76: 797-801.
39. Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: The OFELY study. Osteoporos Int. 2013; 24:489-494.
40. Vasikaran S, Eastell R, Bruyère O, et al IOF-IFCC Bone Marker Standards Working Group. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards. Osteoporos Int. 2011; 22:391-420.